NPI: 1710933692 · SALISBURY, NC 28147 · Internal Medicine Physician · NPI assigned 05/25/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,440 | $98K |
| 2019 | 4,415 | $105K |
| 2020 | 1,972 | $89K |
| 2021 | 7,675 | $145K |
| 2022 | 11,073 | $130K |
| 2023 | 9,807 | $88K |
| 2024 | 10,007 | $28K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,122 | 5,813 | $418K |
| 99199 | Unlisted special service, procedure or report | 33,489 | 32,482 | $116K |
| 99215 | Prolong outpt/office vis | 1,469 | 1,177 | $102K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 848 | 640 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 277 | 239 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 221 | 178 | $1K |
| 99442 | 32 | 26 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 18 | 14 | $833.29 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 44 | 29 | $716.42 |
| 99441 | 28 | 25 | $695.98 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 33 | 17 | $367.38 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 18 | 16 | $351.50 |
| 99308 | Subsequent nursing facility care, per day, straightforward | 68 | 37 | $276.03 |
| 90686 | 14 | 14 | $232.70 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15 | 15 | $217.05 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14 | 12 | $105.38 |
| 81025 | 14 | 12 | $93.60 | |
| 1036F | 718 | 497 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 467 | 307 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 120 | 97 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 696 | 492 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 1,156 | 806 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 272 | 214 | $0.00 |
| 1101F | 56 | 41 | $0.00 | |
| 3017F | 104 | 81 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 123 | 102 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 41 | 24 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 39 | 24 | $0.00 |
| 1123F | 12 | 12 | $0.00 | |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 1,449 | 1,019 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 1,614 | 1,146 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 230 | 152 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 25 | 24 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 124 | 96 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 366 | 251 | $0.00 |
| 4040F | 14 | 12 | $0.00 | |
| 4004F | 39 | 24 | $0.00 |